Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (295)
- Advertising (25)
- Safety monitoring and information (23)
- Manufacturing (11)
- Scheduling (national classification system) (10)
- COVID-19 (7)
- Clinical trials (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Medicinal cannabis hub (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
567 result(s) found, displaying 1 to 25
-
Meeting statementsOverview of the meeting to discuss proposed changes to the Authorised Prescriber application process
-
Meeting statementsCommunique from the 11th meeting of the Women's Health Products Working Group, 30 October 2025
-
Meeting statementsCommunique from the 4th meeting of the Human Research Ethics Committee and TGA Clinical Trials Discussion Forum, 1 December 2025
-
Corporate reportsWe conduct an annual stakeholder survey to improve the way we work with our stakeholders and help report on our key performance indicators.
The report includes data and feedback from the general public (consumers), people and organisations with a TGA business services account (opt-in stakeholders), and state and territory government representatives. -
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 31 July 2025
-
Meeting statementsAdvisory Committee on Vaccines meeting statement 54
-
Meeting statementsMedical device reforms: Consumer Working Group meeting statement, Meeting 17, 22 August 2025
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsThe 87th meeting of the Advisory Committee on Medical Devices (ACMD) was held on 9 October 2025.
-
Meeting statementsCommunique from the 10th meeting of the WHPWG, 17 July 2025
-
Meeting statementsFind out about the AIVC Recommendations for the Composition of Influenza Vaccines for Australia in 2026.
-
Meeting statementsCommunique from the 3rd meeting of the Human Research Ethics Committee and TGA Clinical Trials Discussion Forum, 13 August 2025
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 6 March 2025
-
Meeting statementsThe 86th meeting of the Advisory Committee on Medical Devices (ACMD) was held on 14 August 2025.
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement 53
-
Corporate reportsThe Australian Sunscreen Exposure Model performs sunscreen exposure calculations that reflect the unique conditions and practices in Australia.
-
Meeting statementsCommunique from the 9th meeting of the WHPWG 27 March 2025
-
Corporate reportsRead our business plan 2025-26 to find out about our strategic priorities and activities.
-
Corporate reportsDocuments released under the FOI Act in the 2024/25 financial year
-
Meeting statementsThe 85th meeting of the Advisory Committee on Medical Devices (ACMD) was held on 12 June 2025.
-
Corporate reportsBased on the data considered in this safety review, we recommend regulatory controls for homosalate and oxybenzone to restrict their permitted concentrations and use in therapeutic sunscreens.
-
Corporate reportsThis updated safety review uses the Australian Sunscreen Exposure Model to assess the risk of benzophenone as a degradant in sunscreens.
-
Corporate reportsThis Cost Recovery Implementation Statement (CRIS) 2025-2026 provides information on how we implement, and cost recover our regulatory activities.
-
Meeting statementsAdvisory Committee on Medicines meeting statement